enzymology-and-biotechnology-congress-2017_keynote

5 / 11

Volume 7, Issue 1 (Suppl) J Biotechnol Biomater
ISSN: 2155-952X JBTBM, an open access journal
Enzymology & Mol. Biology 2017
Biotechnology Congress 2017
March 20-21, 2017
Page 33
conferenceseries.com
March 20-21, 2017 Rome, Italy
&
15th World Congress on
2nd International Conference on
Biotechnology And Biotech Industries Meet
Enzymology and Molecular Biology
Choosing between patents and trade secrets for protecting biotech products or bio-production
processes
The choice of trade secrets versus patent protection has taken on renewed importance in the biotechnology sector with
the advent of biosimilar biologics. From an originator perspective, increasing importance is being placed on secondary
patent protection, i.e., patents that cover manufacturing processes, formulations, etc. The goal of these filings is to extend
protection of the original composition and method, and use of patents by covering production methods or the commercial
formulation. However, there are many originator companies which can bypass filing for patent protection, and the disclosure
of their bioprocess that comes with it, in favor of keeping some of their critical processes secret. Factors that weigh in favor of
patent or trade secret protection will be outlined in the context of products versus processes.
Biography
Paul ACalvo is the Director of the Biotechnology/Chemical Group at the Washington, DC-based law firm Sterne Kessler Goldstein & Fox which represents a diverse group
of US and international companies innovating in the field of Biotechnology and Pharmaceuticals Industries. He provides counsel with regard to global patent portfolio strat-
egy, licensing, patent validity, infringement, and design around strategies. He also has extensive expertise in prosecuting and investigating patents related to bio-production
methods and therapeutic formulations. He has extensive technical expertise in the areas of vaccines, therapeutic antibodies, cellular immunology, and bio-therapeutics
during his graduate studies and Post-doctoral fellowships at the University of Pennsylvania and National Institutes of Health.
Paul A Calvo
Sterne Kessler Goldstein & Fox, USA
Paul A Calvo, J Biotechnol Biomater 2017, 7:1(Suppl)